CPHI China 2025 ga-eme site na June 24-26, 2025, na Shanghai New International Expo Center (SNIEC). N'ịgba karịa 230,000 square mita, a na-edozi ihe omume ahụ ka ọ kwadoro ihe ngosi 3,500 ma na-adọta karịa ndị ọkachamara ụlọ ọrụ 100,000. Dị ka otu n'ime ahịa ahịa ọgwụ kachasị ukwuu na Eshia, CPHI China na-enye ikpo okwu na-enweghị atụ maka ịkparịta ụka n'Ịntanet, ihe ọhụrụ, na mmepe azụmahịa.
 
Banyere JYMed
 
JYMed bụ ụlọ ọrụ na-emepụta ọgwụ na teknụzụ dị elu lekwasịrị anya na nyocha, mmepe, nrụpụta na ịzụ ahịa nke ngwaahịa sitere na peptide. Anyị na-enyekwa ọrụ CDMO agbakwunyere n'ụzọ zuru ezu, na-ebuga ngwọta peptide ahaziri maka ndị ahịa ọgwụ, ịchọ mma na ọgwụgwọ anụmanụ n'ụwa niile.
 
Pọtụfoliyo ngwaahịa anyị gụnyere ọtụtụ API peptide. Ngwaahịa ọkọlọtọ dị ka Semaglutide na Tirzepatide emechaala ntinye akwụkwọ US FDA DMF nke ọma.

Enyemaka anyị nwere, Hubei JXBio, na-arụ ọrụ ahịrị mmepụta peptide API ọgbara ọhụrụ wuru iji zute ụkpụrụ cGMP nke US FDA na NMPA nke China setịpụrụ. Ụlọ ọrụ ahụ nwere ahịrị mmepụta 10 buru ibu na nke pilot, nke usoro njikwa ogo ọgwụ siri ike (QMS) na mmemme ahụike na nchekwa gburugburu ebe obibi (EHS) kwadoro.
 
JXBio agafeela nyocha GMP site na US FDA na NMPA nke China wee mara ya site n'aka ndị isi ụlọ ọrụ ọgwụ zuru ụwa ọnụ maka ịdị mma na njikwa EHS, na-egosipụta ntinye anyị na ịdịmma, nchekwa, na nlekọta gburugburu ebe obibi.

Isi ngwaahịa

Kpọtụrụ anyị

Maka ozi ndị ọzọ gbasara ngwaahịa na ọrụ anyị, biko nweta:
● API zuru ụwa ọnụ na ajụjụ ịchọ mma:+ 86-150-1352-9272
● Ndebanye aha API & Ọrụ CDMO (US & EU):+ 86-158-1868-2250
● Email: jymed@jymedtech.com
● Adreesị:Ụlọ elu 8 & 9, Ụlọ 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, China.